| __timestamp | Celldex Therapeutics, Inc. | Zoetis Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 20622000 | 1643000000 |
| Thursday, January 1, 2015 | 33837000 | 1532000000 |
| Friday, January 1, 2016 | 35979000 | 1364000000 |
| Sunday, January 1, 2017 | 25003000 | 1334000000 |
| Monday, January 1, 2018 | 19269000 | 1484000000 |
| Tuesday, January 1, 2019 | 15426000 | 1638000000 |
| Wednesday, January 1, 2020 | 14456000 | 1726000000 |
| Friday, January 1, 2021 | 20488000 | 2001000000 |
| Saturday, January 1, 2022 | 27195000 | 2009000000 |
| Sunday, January 1, 2023 | 30914000 | 2151000000 |
| Monday, January 1, 2024 | 2318000000 |
Unleashing insights
In the competitive landscape of the pharmaceutical industry, understanding the financial health of companies is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Zoetis Inc. and Celldex Therapeutics, Inc. from 2014 to 2023. Over this period, Zoetis Inc. consistently outpaced Celldex in SG&A spending, with figures peaking at approximately $2.15 billion in 2023, marking a 31% increase from 2014. In contrast, Celldex's SG&A expenses showed a more volatile trend, peaking at around $36 million in 2016 before stabilizing to $31 million in 2023. This disparity highlights Zoetis's expansive operational scale compared to Celldex's more focused approach. As the industry evolves, these financial strategies will play a pivotal role in shaping each company's future trajectory.
Operational Costs Compared: SG&A Analysis of Merck & Co., Inc. and Celldex Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Zoetis Inc. and Intra-Cellular Therapies, Inc.
Breaking Down SG&A Expenses: Zoetis Inc. vs Biogen Inc.
Comparing SG&A Expenses: Zoetis Inc. vs Catalent, Inc. Trends and Insights
Zoetis Inc. vs Axsome Therapeutics, Inc.: SG&A Expense Trends
Breaking Down SG&A Expenses: Zoetis Inc. vs TG Therapeutics, Inc.
Breaking Down SG&A Expenses: Zoetis Inc. vs CRISPR Therapeutics AG
SG&A Efficiency Analysis: Comparing Zoetis Inc. and PTC Therapeutics, Inc.
Selling, General, and Administrative Costs: Zoetis Inc. vs Amneal Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of argenx SE and Celldex Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Jazz Pharmaceuticals plc and Celldex Therapeutics, Inc.
Arrowhead Pharmaceuticals, Inc. vs Celldex Therapeutics, Inc.: SG&A Expense Trends